Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor. [electronic resource]
Producer: 20161213Description: 226-32 p. digitalISSN:- 2092-9382
- Angiogenesis Inhibitors -- administration & dosage
- Bevacizumab -- administration & dosage
- Choroid -- blood supply
- Choroid Diseases -- complications
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Humans
- Intravitreal Injections
- Male
- Ranibizumab -- administration & dosage
- Receptors, Vascular Endothelial Growth Factor -- administration & dosage
- Recombinant Fusion Proteins -- administration & dosage
- Retinal Neovascularization -- complications
- Retrospective Studies
- Tomography, Optical Coherence
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity
- Wet Macular Degeneration -- diagnosis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.